SNDD Stock Overview
RedHawk Holdings Corp., through its subsidiaries, engages in sale and distribution of medical devices, and sale of branded generic pharmaceutical drugs primarily in the United States and the United Kingdom.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
RedHawk Holdings Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | -99.50% |
| 3 Year Change | -99.97% |
| 5 Year Change | -99.92% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| SNDD | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 1.0% |
| 1Y | -99.5% | 6.1% | 27.2% |
Return vs Industry: SNDD underperformed the US Healthcare industry which returned -4.2% over the past year.
Return vs Market: SNDD underperformed the US Market which returned 15.2% over the past year.
Price Volatility
| SNDD volatility | |
|---|---|
| SNDD Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: SNDD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SNDD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Philip Spizale | www.redhawkholdingscorp.com |
RedHawk Holdings Corp., through its subsidiaries, engages in sale and distribution of medical devices, and sale of branded generic pharmaceutical drugs primarily in the United States and the United Kingdom. It operates in three segments: Land & Hospitality, Medical Device and Pharmaceutical, and Other Services. The company manufactures and sells Sharps and Needle Destruction Devices; carotid artery digital non-contact thermometers; and Centri Controlled Entry System, a full body X-ray scanner.
RedHawk Holdings Corp. Fundamentals Summary
| SNDD fundamental statistics | |
|---|---|
| Market cap | US$1.40k |
| Earnings (TTM) | -US$1.91m |
| Revenue (TTM) | US$1.61m |
0.0x
P/S Ratio0.0x
P/E RatioIs SNDD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SNDD income statement (TTM) | |
|---|---|
| Revenue | US$1.61m |
| Cost of Revenue | US$818.22k |
| Gross Profit | US$788.73k |
| Other Expenses | US$2.70m |
| Earnings | -US$1.91m |
Last Reported Earnings
Mar 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did SNDD perform over the long term?
See historical performance and comparison